期刊
NANO LETTERS
卷 12, 期 6, 页码 2685-2689出版社
AMER CHEMICAL SOC
DOI: 10.1021/nl2036047
关键词
Protein; nanoparticle; molecular nanotechnology; drug delivery; recombinant protein
类别
资金
- Misrock Foundation
- Life Sciences Research Foundation
- MIT-Harvard Center for Cancer Nanotechnology Excellence [U54 CA151884]
- National Cancer Institute [P30-CA14051]
- NIH [EB000244]
The development of responsive nanomaterials, nanoscale systems that actively respond to stimuli, is one general goal of nanotechnology. Here we develop nanoparticles that can be controllably triggered to synthesize proteins. The nanoparticles consist of lipid vesicles filled with the cellular machinery responsible for transcription and translation, including amino adds, ribosomes, and DNA caged with a photolabile protecting group. These particles served as nanofactories capable of producing proteins including green fluorescent protein (GFP) and enzymatically active luciferase. In vitro and in vivo, protein synthesis was spatially and temporally controllable, and could be initiated by irradiating micrometer-scale regions on the time scale of milliseconds. The ability to control protein synthesis inside nanomaterials may enable new strategies to facilitate the study of orthogonal proteins in a confined environment and for remotely activated drug delivery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据